Evoke Pharma Balance Sheet Health
Financial Health criteria checks 5/6
Evoke Pharma has a total shareholder equity of $2.7M and total debt of $5.0M, which brings its debt-to-equity ratio to 187.6%. Its total assets and total liabilities are $12.1M and $9.5M respectively.
Key information
187.6%
Debt to equity ratio
US$5.00m
Debt
| Interest coverage ratio | n/a |
| Cash | US$9.18m |
| Equity | US$2.66m |
| Total liabilities | US$9.47m |
| Total assets | US$12.14m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: EV0's short term assets ($12.1M) exceed its short term liabilities ($9.5M).
Long Term Liabilities: EV0 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: EV0 has more cash than its total debt.
Reducing Debt: EV0's debt to equity ratio has increased from 0% to 187.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: EV0 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: EV0 has sufficient cash runway for 1.5 years if free cash flow continues to grow at historical rates of 0.9% each year.